Ahmed Idbaih, et al.
ASCO 2017, June 2017 – Download the abstract
Abstract
TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma
Par Lucie Larguier|2019-07-02T10:40:35+02:00juin 5th, 2017|Publication, TG6002|Commentaires fermés sur TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma
À propos de l'auteur : Lucie Larguier
Articles similaires
- Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
Design of an Innovative Model to Improve Anticancer Therapeutic Treatment Based on a Vascularized 3D Organoids Derived from Patients’ Lung Tumors for the Purpose of Precision Medicine
- BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment